https://biotechmorning.com/news/ge-healthcare-sofie-biosciences-acquisition Biotech Morning en 2026-09-16T14:17:28.103Z GE HealthCare Wants to Buy the Bullets for Its Own Guns https://biotechmorning.com/news/fda-operation-trialblazer-accelerate-phase-1-trials Biotech Morning en 2026-09-16T14:16:42.969Z The FDA Wants to Shave a Year Off Your Drug's Timeline https://biotechmorning.com/news/astrazeneca-15-billion-ivonescimab-summit-deal Biotech Morning en 2026-09-16T14:15:56.704Z AstraZeneca's $15 Billion Bet on a Drug You've Never Heard Of https://biotechmorning.com/news/roche-hanmi-obesity-muscle-preservation-deal Biotech Morning en 2026-09-16T14:15:12.036Z Roche's $2.3 Billion Bet on a Muscle That Won't Quit https://biotechmorning.com/news/sionna-therapeutics-cystic-fibrosis-layoffs Biotech Morning en 2026-09-16T14:14:26.213Z The $330M Bet on Fixing a Broken Protein That Just Blew Up https://biotechmorning.com/news/ai-drug-rentosertib-phase-3-pulmonary-fibrosis Biotech Morning en 2026-09-16T14:13:43.367Z An AI Built This Drug From Scratch. Now It Faces Its Biggest Test. https://biotechmorning.com/news/lilly-2-9-billion-merida-biosciences-acquisition Biotech Morning en 2026-09-16T14:12:55.471Z Lilly's $2.9 Billion Bet on a Company You've Never Heard Of https://biotechmorning.com/news/lutathera-first-generic-radioligand-copycat Biotech Morning en 2026-09-16T14:12:14.110Z Lutathera Just Got Its First Copycat. Radioligand Therapy Will Never Be the Same. https://biotechmorning.com/news/merck-kgaa-bio-techne-11-billion-acquisition-2 Biotech Morning en 2026-09-16T14:11:29.063Z Merck KGaA Just Made Its Biggest Bet in a Decade. Here's What It's Buying. https://biotechmorning.com/news/gsk-chimagen-750m-myeloma-deal Biotech Morning en 2026-09-15T14:15:17.511Z GSK Just Wrote a $750M Check for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/moderna-mflusiva-mrna-flu-vaccine-fda-approval-2 Biotech Morning en 2026-09-15T14:14:31.058Z Moderna Just Proved mRNA Isn't a One-Hit Wonder https://biotechmorning.com/news/lilly-kills-obesity-drug-smart-move Biotech Morning en 2026-09-15T14:13:44.081Z Lilly Just Killed an Obesity Drug. That's Actually the Smart Move. https://biotechmorning.com/news/corbus-obesity-drug-cb1-novo-nordisk Biotech Morning en 2026-09-15T14:12:58.955Z The Obesity Drug That Worked Where Novo Nordisk Couldn't https://biotechmorning.com/news/biontech-gotistobart-doubles-survival-squamous-lung-cancer Biotech Morning en 2026-09-15T14:12:07.603Z BioNTech's Lung Cancer Drug Just Doubled What Chemo Could Do https://biotechmorning.com/news/fda-psychedelic-therapy-approval-hearing Biotech Morning en 2026-09-15T14:11:23.375Z The FDA Just Opened the Door to Prescribing Magic Mushrooms https://biotechmorning.com/news/novo-nordisk-walks-away-285m-ascendis-glp1-deal Biotech Morning en 2026-09-15T14:10:35.135Z Novo Nordisk Just Walked Away from a $285M Obesity Bet. Why? https://biotechmorning.com/news/jnj-contineum-depression-drug-phase-2-failure Biotech Morning en 2026-09-15T14:09:46.674Z J&J's Antidepressant Keeps Striking Out, and Nobody's Surprised